
Andrographis no longer allowed in new listed medicines sold in Australia
Andrographis paniculata is no longer allowed in new listed medicines sold in Australia, starting from Sept. 17, 2026, the local regulator, the Therapeutic Goods Administration (TGA), announced. Sponsors of existing Andrographis products will be receiving...









